Well another quarter has passed and it's been pretty quiet so far. We know from several sources that the second half of 2009 production is already spoken for, but how has this translated to sales for the Sept quarter?
GSK timetable:
http://www.gsk.com/investors/ne_financial_calendar.htm
Looks like Oct 28th is D-Day for this quarter.
A wild guess, I'll tip $35m. Closest without going higher is the winner.